These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 3305939

  • 21. [Mechanisms of degradation of argecanes in osteoarthritic cartilage].
    Lohmander LS, Lark MW, Sandy JD.
    Rev Prat; 1996 Mar 15; 46(6 Spec No):S11-S14. PubMed ID: 8731724
    [No Abstract] [Full Text] [Related]

  • 22. The serine protease inhibitor trappin-2 is present in cartilage and synovial fluid in osteoarthritis.
    Jaovisidha K, Etim A, Yamakawa K, Masuda I, Gohr CM, Wakim BT, Boonapatcharoen N, Ninomiya J, Rosenthal AK.
    J Rheumatol; 2006 Feb 15; 33(2):318-25. PubMed ID: 16465664
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Analysis of normal and osteoarthritic canine cartilage mRNA expression by quantitative polymerase chain reaction.
    Clements DN, Carter SD, Innes JF, Ollier WE, Day PJ.
    Arthritis Res Ther; 2006 Feb 15; 8(6):R158. PubMed ID: 17032449
    [Abstract] [Full Text] [Related]

  • 26. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR.
    Arthritis Rheum; 2005 Jan 15; 52(1):128-35. PubMed ID: 15641080
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis.
    Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL, Flannery CR, Peluso D, Kanki K, Yang Z, Majumdar MK, Morris EA.
    Nature; 2005 Mar 31; 434(7033):644-8. PubMed ID: 15800624
    [Abstract] [Full Text] [Related]

  • 29. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M, Kuboki T, Kojima S, Fujisawa T, Hattori T, Takigawa M, Yamashita A.
    J Orofac Pain; 2000 Mar 31; 14(1):20-30. PubMed ID: 11203734
    [Abstract] [Full Text] [Related]

  • 30. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes.
    Loeser RF, Pacione CA, Chubinskaya S.
    Arthritis Rheum; 2003 Aug 31; 48(8):2188-96. PubMed ID: 12905472
    [Abstract] [Full Text] [Related]

  • 31. Interactions of proteases, protease inhibitors, and the beta1 integrin/laminin gamma3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis.
    Siu MK, Cheng CY.
    Biol Reprod; 2004 Apr 31; 70(4):945-64. PubMed ID: 14645107
    [Abstract] [Full Text] [Related]

  • 32. Matrix metalloproteases are involved in granuloma-induced cartilage degradation.
    Trancart MM, Chalmeigne N, Girardot C, Zarpanelian C, Prigent D.
    Int J Tissue React; 1991 Apr 31; 13(4):165-9. PubMed ID: 1821411
    [Abstract] [Full Text] [Related]

  • 33. Sulfate metabolism in human chondrocyte cultures.
    Schwartz ER, Kirkpatrick PR, Thompson RC.
    J Clin Invest; 1974 Nov 31; 54(5):1056-63. PubMed ID: 4417960
    [Abstract] [Full Text] [Related]

  • 34. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
    Hardy MM, Seibert K, Manning PT, Currie MG, Woerner BM, Edwards D, Koki A, Tripp CS.
    Arthritis Rheum; 2002 Jul 31; 46(7):1789-803. PubMed ID: 12124863
    [Abstract] [Full Text] [Related]

  • 35. Osteoarthritis: differential expression of matrix metalloproteinase-9 mRNA in nonfibrillated and fibrillated cartilage.
    Tsuchiya K, Maloney WJ, Vu T, Hoffman AR, Huie P, Sibley R, Schurman DJ, Smith RL.
    J Orthop Res; 1997 Jan 31; 15(1):94-100. PubMed ID: 9066532
    [Abstract] [Full Text] [Related]

  • 36. Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro.
    Caputo CB, Sygowski LA, Wolanin DJ, Patton SP, Caccese RG, Shaw A, Roberts RA, DiPasquale G.
    J Pharmacol Exp Ther; 1987 Feb 31; 240(2):460-5. PubMed ID: 3543299
    [Abstract] [Full Text] [Related]

  • 37. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis.
    Lorenzo P, Bayliss MT, Heinegård D.
    Matrix Biol; 2004 Oct 31; 23(6):381-91. PubMed ID: 15533759
    [Abstract] [Full Text] [Related]

  • 38. Application of new techniques to separation of proteoglycan aggregates from normal and destabilized rabbit articular cartilages.
    Manicourt D, Howell DS, Moskowitz RW, Goldberg V, Malemud C, Pita JC.
    Acta Biol Hung; 1984 Oct 31; 35(2-4):137-42. PubMed ID: 6242443
    [Abstract] [Full Text] [Related]

  • 39. The role of proteases in the pathogenesis of osteoarthritis.
    Ehrlich MG, Armstrong AL, Treadwell BV, Mankin HJ.
    J Rheumatol; 1987 May 31; 14 Spec No():30-2. PubMed ID: 3040991
    [Abstract] [Full Text] [Related]

  • 40. Cartilage degradation by neutral proteoglycanases in experimental osteoarthritis. Suppression by steroids.
    Pelletier JP, Martel-Pelletier J.
    Arthritis Rheum; 1985 Dec 31; 28(12):1393-401. PubMed ID: 3910049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.